We examined the effect of NCL-1 treatment in vitro on typical tumor cell functions in neuroblastoma cells and compared these cell phenotypes with the previously reported cellular phenotype induced by siRNA-mediated KDM1A knockdown [10]. This evidence concerns the gene CAPN3 and neuroblastoma.